Phase I/II dose-escalation and expansion study of afuresertib plus carboplatin and paclitaxel in recurrent ovarian cancer.

Sarah Patricia Blagden; Hani Gabra; Anne L. Hamilton; Shirley S. Wong; Agnieszka Michael; Linda R. Mileshkin; Marcia Hall; Jeffrey Goh; Alla Sergeevua Lisyanskaya; Michelle DeSilvio; Dany Habr; Shelby Gainer; Prashanth Gopalakrishna; Tarek Meniawy

doi:10.1200/JCO.2016.34.15_suppl.2551

Phase I/II dose-escalation and expansion study of afuresertib plus carboplatin and paclitaxel in recurrent ovarian cancer.

Sarah Patricia Blagden, Hani Gabra, Anne L. Hamilton, Shirley S. Wong, Agnieszka Michael, Linda R. Mileshkin, Marcia Hall, Jeffrey Goh, Alla Sergeevua Lisyanskaya, Michelle DeSilvio, Dany Habr, Shelby Gainer, Prashanth Gopalakrishna, Tarek Meniawy

UWA Medical School

Research output: Contribution to journal › Abstract/Meeting Abstract › peer-review

3 Citations (Web of Science)

Original language	English
Number of pages	2
Journal	Journal of Clinical Oncology
Volume	34
Issue number	15
DOIs	https://doi.org/10.1200/JCO.2016.34.15_suppl.2551
Publication status	Published - 20 May 2016
Event	52nd Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) - Chicago, United States Duration: 3 Jun 2016 → 7 Jun 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1200/JCO.2016.34.15_suppl.2551

Cite this

Blagden, S. P., Gabra, H., Hamilton, A. L., Wong, S. S., Michael, A., Mileshkin, L. R., Hall, M., Goh, J., Lisyanskaya, A. S., DeSilvio, M., Habr, D., Gainer, S., Gopalakrishna, P., & Meniawy, T. (2016). Phase I/II dose-escalation and expansion study of afuresertib plus carboplatin and paclitaxel in recurrent ovarian cancer. Journal of Clinical Oncology, 34(15). https://doi.org/10.1200/JCO.2016.34.15_suppl.2551

@article{79d0ab24b0324a3b851730a2b77996e2,

title = "Phase I/II dose-escalation and expansion study of afuresertib plus carboplatin and paclitaxel in recurrent ovarian cancer.",

author = "Blagden, {Sarah Patricia} and Hani Gabra and Hamilton, {Anne L.} and Wong, {Shirley S.} and Agnieszka Michael and Mileshkin, {Linda R.} and Marcia Hall and Jeffrey Goh and Lisyanskaya, {Alla Sergeevua} and Michelle DeSilvio and Dany Habr and Shelby Gainer and Prashanth Gopalakrishna and Tarek Meniawy",

year = "2016",

month = may,

day = "20",

doi = "10.1200/JCO.2016.34.15_suppl.2551",

language = "English",

volume = "34",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "American Society of Clinical Oncology",

number = "15",

note = "52nd Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) ; Conference date: 03-06-2016 Through 07-06-2016",

}

Blagden, SP, Gabra, H, Hamilton, AL, Wong, SS, Michael, A, Mileshkin, LR, Hall, M, Goh, J, Lisyanskaya, AS, DeSilvio, M, Habr, D, Gainer, S, Gopalakrishna, P & Meniawy, T 2016, 'Phase I/II dose-escalation and expansion study of afuresertib plus carboplatin and paclitaxel in recurrent ovarian cancer.', Journal of Clinical Oncology, vol. 34, no. 15. https://doi.org/10.1200/JCO.2016.34.15_suppl.2551

TY - JOUR

T1 - Phase I/II dose-escalation and expansion study of afuresertib plus carboplatin and paclitaxel in recurrent ovarian cancer.

AU - Blagden, Sarah Patricia

AU - Gabra, Hani

AU - Hamilton, Anne L.

AU - Wong, Shirley S.

AU - Michael, Agnieszka

AU - Mileshkin, Linda R.

AU - Hall, Marcia

AU - Goh, Jeffrey

AU - Lisyanskaya, Alla Sergeevua

AU - DeSilvio, Michelle

AU - Habr, Dany

AU - Gainer, Shelby

AU - Gopalakrishna, Prashanth

AU - Meniawy, Tarek

PY - 2016/5/20

Y1 - 2016/5/20

U2 - 10.1200/JCO.2016.34.15_suppl.2551

DO - 10.1200/JCO.2016.34.15_suppl.2551

M3 - Abstract/Meeting Abstract

SN - 0732-183X

VL - 34

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 15

T2 - 52nd Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO)

Y2 - 3 June 2016 through 7 June 2016

ER -